There are currently 41 clinical trials in West Valley City, Utah looking for participants to engage in research studies. Trials are conducted at various facilities, including START Mountain Region and Granger Medical Clinic. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3)
Recruiting
The study will be conducted in 2 cohorts. A single-center design for the tumor microenvironment (TME) cohort (Cohort 1), and a multicenter design for the less frequent intravenous (IV) dosing cohort (Cohort 2).
Gender:
All
Ages:
18 years and above
Trial Updated:
01/23/2024
Locations: Mural Oncology Investigator Site, West Valley City, Utah
Conditions: Advanced Solid Tumor
Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
Recruiting
The OLE study aims to investigate the safety, efficacy, pharmacodynamics (PD), pharmacokinetics (PK), and immunogenicity of efgartigimod in participants with post-COVID-19 postural orthostatic.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/02/2024
Locations: Metrodora Institute, West Valley City, Utah
Conditions: Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
Recruiting
This is a phase 1, multi-center, open-label, dose-escalation study of nab-sirolimus in adult patients with locally advanced or metastatic solid tumors and moderate hepatic impairment or normal hepatic function.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/15/2023
Locations: START Mountain Region, West Valley City, Utah
Conditions: Tumor, Solid, Tumor, Advanced Solid Tumor
A Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR and Anti-c-MET Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Recruiting
A phase 1/2 open-label multicenter study will be performed with an initial dose escalation part to determine the MTD and/or the RP2D of MCLA-129 as monotherapy in patients with NSCLC, HNSCC, GC/GEJ, ESCC, or other solid tumors and who have progressed after receiving prior therapy for advanced/metastatic disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/07/2023
Locations: START Mountain Region, West Valley City, Utah
Conditions: Non-Small Cell Lung Cancer Metastatic, Gastric Cancer, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
Improving Health Insurance Literacy Among Utah's Hispanic Population
Recruiting
This is a test of an existing health insurance education program (HIEP) in the Utah Hispanic community (aged 18-64). The study will evaluate whether the HIEP delivered by Utah Health Policy Project (UHPP) staff improves participants' health insurance and cost-related literacy. Participants will complete a brief baseline survey, be guided through the HIEP by UHPP staff, and complete a brief survey/interview after completing the sessions.
Gender:
All
Ages:
Between 18 years and 64 years
Trial Updated:
05/03/2023
Locations: Utah Health Policy Project, West Valley City, Utah
Conditions: Health Knowledge, Attitudes, Practice